New research with mice suggests aging is an important component of retinal ganglion cell death in glaucoma.
The researchers also report that novel pathways can be targeted when designing new treatments for glaucoma patients.

The researchers also report that novel pathways can be targeted when designing new treatments for glaucoma patients.